Literature DB >> 20346238

Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study.

C-Y Chen1, Y-H Chen, H-C Lin, S-F Chen, H-C Lin.   

Abstract

OBJECTIVES: Using a nationwide population-based dataset to examine the risk of adverse pregnancy outcomes in women with systemic lupus erythematosus (SLE), with and without SLE hospitalisation during pregnancy.
METHODS: We identified 1,010 pregnant women who had SLE during 2001 2003 as the study cohort and 5,050 randomly selected pregnant women (five for every woman with SLE) as a comparison cohort. Conditional logistic regression analyses were performed to explore the relationship between women with and without SLE and the risk of low birth weight (LBW), preterm birth, and babies small for gestational age (SGA), after adjusting for the characteristics of the infant, mother, and father.
RESULTS: We found that there were significant differences in the risk of LBW (14.9% vs. 7.2%), preterm birth (14.4% vs. 8.5%), and SGA (28.5% vs. 17.5%) for women with SLE compared to women without. In addition, the adjusted odds of LBW, preterm birth, and SGA babies for women who had SLE during pregnancy were 6.15 (95% CI=4.15-9.13), 4.19 (95% CI=2.77-6.36), and 4.25 (95% CI=2.95-6.11) times, respectively, compared to women without any chronic illness. The adjusted odds of LBW, preterm birth, and SGA babies for women who had SLE but were not hospitalized during pregnancy were 1.80 (95% CI=1.43-2.26), 1.62 (95% CI=1.30-2.03), and 1.63 (95% CI=1.38-1.94) times, respectively, compared to unaffected mothers.
CONCLUSIONS: We conclude that SLE can impact the pregnancy outcomes, especially if hospitalisation occurs during the pregnancy.

Entities:  

Mesh:

Year:  2010        PMID: 20346238

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Predictors of maternal and fetal complications in SLE patients: a prospective study.

Authors:  Elisabetta Borella; Andrea Lojacono; Mariele Gatto; Laura Andreoli; Marco Taglietti; Luca Iaccarino; Edoardo Casiglia; Leonardo Punzi; Angela Tincani; Andrea Doria
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy.

Authors:  Miguel A Saavedra; Claudia Cruz-Reyes; Olga Vera-Lastra; Griselda T Romero; Polita Cruz-Cruz; Rafael Arias-Flores; Luis J Jara
Journal:  Clin Rheumatol       Date:  2012-01-27       Impact factor: 2.980

3.  A Population-based Study of Perinatal Infection Risk in Women with and without Systemic Lupus Erythematosus and their Infants.

Authors:  Rachel A Bender Ignacio; Amy T Madison; Ata Moshiri; Noel S Weiss; Beth A Mueller
Journal:  Paediatr Perinat Epidemiol       Date:  2017-12-01       Impact factor: 3.980

4.  Oral corticosteroid use during pregnancy and risk of preterm birth.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Min Xi; Diana L Johnson; Ronghui Xu; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

5.  Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study.

Authors:  Wen Di; Wei-Hong Zhang; Jiayue Wu; Jinghang Ma; Chunde Bao
Journal:  BMJ Open       Date:  2018-04-13       Impact factor: 2.692

6.  Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period.

Authors:  Jorge Lima; Geraldine Cambridge; Andreia Vilas-Boas; Catarina Martins; Luís-Miguel Borrego; Maria Leandro
Journal:  Am J Reprod Immunol       Date:  2019-01-30       Impact factor: 3.886

7.  Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study.

Authors:  Wei-Hong Zhang; Wen Di; Jiayue Wu; Jinghang Ma; Chunde Bao; Jinlin Liu
Journal:  BMJ Open       Date:  2019-02-11       Impact factor: 2.692

8.  Use of a screening questionnaire for systemic lupus erythematosus among pregnant women in a Mexican population.

Authors:  Luis Lucero-Morales; Juanita Romero-Diaz; Diana Yazmin Copado-Mendoza; María Del Carmen Zamora-Medina; Sandra Acevedo-Gallegos; Juan Manuel Gallardo-Gaona; Berenice Velazquez-Torres; Jose Antonio Ramirez-Calvo; Dulce Maria Camarena-Cabrera; Maria Jose Rodriguez-Sibaja
Journal:  Lupus Sci Med       Date:  2021-06

9.  Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program.

Authors:  Kristin Palmsten; Gretchen Bandoli; Jim Watkins; Gabriela Vazquez-Benitez; Todd P Gilmer; Christina D Chambers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.